Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.
Authors:
- D K WagnerDWD K Wagner
- J KiwanukaJKJ Kiwanuka
- B K EdwardsBEB K Edwards
- L A RubinLRL A Rubin
- D L NelsonDND L Nelson
- I T MagrathIMI T Magrath
- 1 August 1987
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 5 (8) , 1262-1274
Abstract
We have been able to detect soluble interleukin-2 receptors (IL-2R) in pretreatment sera from 80 patients with undifferentiated lymphoma (predominantly Burkitt's lymphoma) and lymphoblastic lymphoma. The demonstration of IL-2R in lymphoma-derived cell lines by immunoprecipitation and direct staining indicates that IL-2R is synthesized by the tumor cells. Comparisons were made with two other subject groups: 42 sarcoma patients and 17 normal individuals. The distribution of soluble IL-2R values for lymphoma patients (geometric mean, 1,132 U/mL) was significantly greater than that of sarcoma patients (geometric mean, 332 U/mL; P = .0001) or normal individuals (geometric mean, 238 U/mL; P = .0001). Patients with undifferentiated lymphoma stages B, C, and D had significantly higher soluble IL-2R values (geometric mean, 1,648 U/mL) than stages A and AR (geometric mean, 706 U/mL; P = .0001) or lymphoblastic lymphoma (geometric mean, 826 U/mL; P = .0002). Within the lymphoma group, the soluble IL-2R level was found to be the most significant prognostic indicator of disease-free interval and survival when compared with other previously recognized factors such as histology, stage, bone marrow involvement at presentation, lactic dehydrogenase (LDH), uric acid (UA), and age. No factor was significantly associated with response to therapy, ie, the initial achievement of complete remission (CR) status, although small numbers of patients with a partial response limit interpretation. Soluble IL-2R levels were measured serially in two patients and were found to be elevated at presentation or relapse and to decrease to normal levels during periods of disease remission. IL-2R appears to reflect tumor burden and may prove to be a useful and specific marker for lymphoid tumors.Keywords
This publication has 21 references indexed in Scilit:
- Serum Total and Isoenzyme Lactate Dehydrogenase Activity in American Burkitt’s Lymphoma PatientsAmerican Journal of Clinical Pathology, 1982
- AGE AND SEX AS FACTORS INFLUENCING REMISSION DURATION IN AFRICAN BURKITTS LYMPHOMAAmerican Journal of Epidemiology, 1982
- Separable helper factors support B cell proliferation and maturation to Ig secretion.The Journal of Immunology, 1982
- B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.Journal of Experimental Medicine, 1981
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceJournal of Experimental Medicine, 1981
- In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.The Journal of Immunology, 1981
- Prognostic factors in Burkitt's lymphoma importance of total tumor burdenCancer, 1980
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Treatment Results of 54 American Patients with Burkitt's Lymphoma Are Similar to the African ExperienceNew England Journal of Medicine, 1977
- MULTIPLE FORMS OF ENZYMES: TISSUE, ONTOGENETIC, AND SPECIES SPECIFIC PATTERNSProceedings of the National Academy of Sciences, 1959